Douglas Emmett (NYSE:DEI – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $1.64-$1.70 for the period, compared to the consensus estimate of $1.67.
Douglas Emmett Trading Down 1.1 %
Shares of DEI stock traded down $0.15 on Tuesday, hitting $13.75. 2,096,751 shares of the stock traded hands, compared to its average volume of 1,850,887. Douglas Emmett has a twelve month low of $10.09 and a twelve month high of $16.12. The firm’s 50-day moving average price is $13.43 and its two-hundred day moving average price is $13.36. The company has a current ratio of 4.91, a quick ratio of 4.91 and a debt-to-equity ratio of 1.44.
Douglas Emmett Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, April 16th. Stockholders of record on Thursday, March 28th were issued a dividend of $0.19 per share. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 5.53%. Douglas Emmett’s dividend payout ratio is currently -292.31%.
Analyst Upgrades and Downgrades
View Our Latest Analysis on Douglas Emmett
Douglas Emmett Company Profile
Douglas Emmett, Inc (DEI) is a fully integrated, self-administered and self-managed real estate investment trust (REIT), and one of the largest owners and operators of high-quality office and multifamily properties located in the premier coastal submarkets of Los Angeles and Honolulu. Douglas Emmett focuses on owning and acquiring a substantial share of top-tier office properties and premier multifamily communities in neighborhoods that possess significant supply constraints, high-end executive housing and key lifestyle amenities.
Featured Stories
- Five stocks we like better than Douglas Emmett
- What Are Dividend Champions? How to Invest in the Champions
- Garmin Navigates to New Highs Driven By Wearables Trend
- P/E Ratio Calculation: How to Assess Stocks
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Douglas Emmett Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Douglas Emmett and related companies with MarketBeat.com's FREE daily email newsletter.